Expression of porcine endogenous retroviruses (PERV) in different organs of a pig  by Bittmann, Iris et al.
Virology 433 (2012) 329–336Contents lists available at SciVerse ScienceDirectVirology0042-68
http://d
n Corr
E-mjournal homepage: www.elsevier.com/locate/yviroExpression of porcine endogenous retroviruses (PERV) in different
organs of a pigIris Bittmann a, Debora Mihica b, Roland Plesker c, Joachim Denner b,n
a Institute of Pathology, Rotenburg, Germany
b Robert Koch Institute, Berlin, Germany
c Paul Ehrlich Institute, Langen, Germanya r t i c l e i n f o
Article history:
Received 22 May 2012
Returned to author for revisions
21 June 2012
Accepted 18 August 2012
Available online 11 September 2012
Keywords:
Porcine endogenous retrovirus
Xenotransplantation
Expression
Immunohistochemistry22/$ - see front matter & 2012 Elsevier Inc. A
x.doi.org/10.1016/j.virol.2012.08.030
esponding author. Fax: þ49 30 18754 2334.
ail address: DennerJ@rki.de (J. Denner).a b s t r a c t
Porcine endogenous retroviruses (PERVs) represent a particular risk for xenotransplantation using pig
cells, tissues or organs. PERVs are integrated in the genome of all pig strains and can be released as
particles that infect human cells. We performed for the ﬁrst time a systematic analysis of PERV
expression in different organs of a miniature pig using in parallel quantitative real-time RT-PCR,
Western blot analysis, and immunohistochemistry. All three types of PERV, PERV-A, PERV-B and PERV-C
were present in the germ line of the animal. In addition, recombinant PERV-A/C were detected in some
tissues, but not in the germ line. Expression of the viral full-length and spliced mRNA and proteins was
found in many organs, but at different levels. A high expression was found in lymphoid organs.
& 2012 Elsevier Inc. All rights reserved.Introduction
Pig – to – human xenotransplantation is considered to be a
promising approach to alleviate the shortage of human allogenic
donor organs (Yang and Sykes, 2007). However, prior to the
clinical use of porcine xenotransplants, three main hurdles have
to be overcome: the immunological rejections, the physiological
incompatibility and the risk of transmission of porcine pathogens.
The premier immunological hurdle, the hyperacute rejection
(HAR), which is due to the stimulation of the human complement
system through the gal alpha 1,3 gal epitopes on the surface of
porcine cells can be overcome in a clinically acceptable manner
by either the production of Gal knock-out animals (Dai et al.,
2002; Lai et al., 2002) or animals expressing human complement
regulatory factors (for review see Petersen et al., 2009). Transmis-
sion of most porcine microbes can be prevented by designated
pathogen-free breeding of the animals (for review see Denner and
To¨njes, 2012). Porcine endogenous retroviruses (PERVs) are con-
sidered to be the major microbiological risk if pig cells, tissues or
organs are to be transplanted as they (i) are integrated in
numerous copies in the genome of all pig strains (Patience
et al., 1997,2001; Ericsson et al., 2001), (ii) are produced by
normal pig cells (Le Tissier et al., 1997; Martin et al., 1998; Wilson
et al., 2000; Tacke et al., 2003), (iii) infect human cell in vitro
(Patience et al., 1997; Martin et al., 1998; Specke et al., 2001) andll rights reserved.(iv) have immunosuppressive properties (Denner, 1998; Tacke
et al., 2000). Transspecies transmission of retroviruses is common
and may result in immunodeﬁciencies as in the case of the human
immunodeﬁciency virus HIV-1, in tumors as in the case of the
human T-cell leukemia virus HTLV-1, or may be clinically silent as
in the case of foamy viruses (for review see Denner, 2007). Three
subclasses of infectious PERV have been described, PERV-A and
PERV-B, infecting cells of different species (polytropic) including
human cells (human-tropic) as well as PERV-C infecting only pig
cells (ecotropic) (Takeuchi et al., 1998, for review see Wilson,
2008). In addition, replication competent recombinant PERV-A/C
were found in normal and melanoma-bearing pigs (Wood et al.,
2004; Dieckhoff et al., 2007). The recombinants were found
integrated in the genome of some somatic cells of the animals,
but they were not present in the germ line. PERV-A/C are
characterized by high-titer replication and speciﬁc mutations
when compared with the parental PERV-A and they are able to
infect human cells (for review see Denner, 2008).
Until now, evidence for PERV transmission was neither seen in
patients who had received porcine xenotransplants nor in butch-
ers frequently exposed to pig tissues (Elliott et al., 2000;
Garkavenko et al., 2004; Paradis et al., 1999; Tacke et al., 2001).
Similarly, rats, rhesus macaques, pig tailed macaques and
baboons inoculated with high doses of PERV and given strong
daily immunosuppressive treatment failed to exhibit evidence of
infection (for review see Denner et al., 2009). Only in guinea pigs
a transient infection was observed (Argaw et al., 2004).
Studying expression of PERV in untreated and mitogen treated
PBMCs from different pig strains showed that some pig strains
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others such as the German landrace pigs expressed lower
amounts (Tacke et al., 2000,2003). Among the Yucatan miniature
pigs, the animal 385 had a very high expression (Tacke et al.,
2003). PBMCs from pig 385 released a high amount of PERV
particles (as measured by reverse transcriptase activity) when
cultured in medium and the release increased after stimulation
with the mitogen phytohemagglutinin (PHA). In particles pelleted
from the supernatant of cultured PBMCs the genomes of PERV-A,
PERV-B, and PERV-C were found by RT-PCR using speciﬁc primers
for all three PERVs. This indicated that all three viruses were
released. Kinetic studies showed a peak of expression at day
4 after addition of PHA (Tacke et al., 2003). When analyzing the
expression of PERV in PBMCs from 181 non-transgenic and
transgenic pigs, among them pig 385, at a later time point, the
expression in PBMCs from this animal was conﬁrmed to be very
high. When the PBMCs were untreated, the expression of PERV
was 10.48% of the expression in PK-15 cells, after stimulation
with PHA the expression was 93% of the level in PK-15 cells set
100% (Dieckhoff et al., 2009). This was the highest value of PERV
expression of all pigs analyzed. Stimulated PBMCs from the other
pigs showed an expression of PERV between 0.17% and 43.9% of
that in PK-15 cells. Reverse transcriptase activity was also found
in the supernatant of PHA-treated PBMCs from pig 385, conﬁrm-
ing release of virus particles (Dieckhoff et al., 2009).
The expression of PERV in different organs, especially in organs
relevant for xenotransplantation, was not yet studied in detail.
Only a limited number of organs was analyzed and differences in
the expression in different organs were observed with highest
expression in the lung and the thymus of miniature swines
(Akiyoshi et al., 1998), in the kidneys and the liver of a Large
White pig (Clemenceau et al., 1999), in the spleen and the lung of
miniature pigs with melanomas (Dieckhoff et al., 2007) or of
transgenic German landrace pigs (Dieckhoff et al., 2008; Semaan
et al., 2012). To study a larger number of tissues and organs and to
compare expression at the mRNA and protein level, the Yucatan
miniature pig 385, characterized by high expression of PERV, was
analyzed. For the ﬁrst time expression of mRNA and protein was
simultaneously investigated. For the ﬁrst time the expression of
spliced and unspliced mRNA was analyzed in pig tissues.
Although this is only one animal that was studied in such a
detailed manner, smaller studies had also shown differences in
the expression of PERV in different organs (Supplementary
Table 1), suggesting that selection of animals for xenotransplan-
tation should be organ-speciﬁc. However there was a good
correlation between the expression in PBMCs and in the whole
organism, allowing easy prescreening of the animals.Results
Expression of PERV in PBMCs
During the life-time of pig 385, the expression of PERV in the
PBMCs was measured repeatedly (Tacke et al., 2000,2003;
Dieckhoff et al., 2009). Animal 385 was shown to harbor all three
types of PERV, PERV-A, PERV-B, and PERV-C in the germ line
(Tacke et al., 2000). The high expression of PERV mRNA correlated
with the release of reverse transcriptase (RT) activity and virus
particles into the supernatant. The RT release correlated with
mitogen-induced cell proliferation measured as 3H-thymidine
incorporation in the PBMCs. Genomic RNA of PERV-A, PERV-B,
and PERV-C was found in virus pellets indicating that all three
viruses were released (Tacke et al., 2003). Attempts to infect
highly susceptible human 293 cells with the released particles,
however, failed (not shown).Expression of PERV mRNA in different organs
When the animal was sacriﬁced at an age of 8 years, samples
taken from different organs were investigated for PERV expression.
To determine the expression at the mRNA level, total RNA was
isolated and a real-time PCR was performed. One real-time RT-PCR
was based on primers speciﬁc for the gag sequence, the second
using primers speciﬁc for the pol sequence (Table 1), both measur-
ing the expression of the full-length mRNA coding for Gag and Pol
of PERVs. Both assays gave similar results (Fig. 1). In addition, a
real-time RT-PCR was performed analyzing the expression of PERV-
C using primers speciﬁc for PERV-C and for a newly described
variant of PERV-C with differences in the nucleotide sequence in
the receptor binding site of the surface envelope protein (Kaulitz
et al., 2011b) (Fig. 1). The highest expression of the full-length
mRNA of PERV-A was found in the lung, spleen, and lymph nodes,
in the other organs the expression was low. A very low expression
was found in the pancreas (the integrity of the RNA had been
shown in a duplex real-time PCR using porcine cyclophilin). The
highest expression of PERV-C was found in the lung, the expression
in the spleen and lymph nodes was low (Fig. 1).
The expression of gammaretroviruses is characterized by
expression of a full length mRNA encoding for Gag and Pol and
of a spliced mRNA encoding for Env. To study the expression of
the spliced mRNA of PERV-A, speciﬁc primers were developed
allowing the discrimination between full-length and spliced
mRNA (Table 1, Fig. 2A). The expression of the spliced mRNA is
a prerequisite for the production of Env protein. High expression
of the spliced env mRNA was found in the lung, in the spleen and
in the brain, a lower expression was found in the liver and in the
ovarian tissue (Fig. 2B). The high expression of the spliced mRNA
in the lung correlated with the high expression of the full length
mRNA in this organ, in the spleen full-length and spliced mRNA
were expressed at an intermediate level (Figs. 1 and 2B). Inter-
estingly, in PK15 cells expression of different types of spliced
mRNA was found (Fig. 2B, C).
Detection and expression of recombinant PERV-A/C
To detect PERV-A/C proviruses, DNA from different organs was
analyzed using a speciﬁc semiquantitative PCR (Table 1). Pro-
viruses of PERV-A/C were detected in the kidney, in the liver, in
the brain, and in the spleen (Fig. 3). The copy number was high in
the kidney and lower in the other organs. There was no detectable
PERV-A/C in other tissues investigated, indicating that PERV-A/C
was not present in the germ line. Expression of PERV-A/C was
analyzed using a RT-PCR, however no expression above the
sensitivity of the assay was observed (not shown).
Expression of PERV protein in different organs
To study PERV expression at the protein level in single cells,
immunohistochemistry was performed using two PERV-speciﬁc
immune sera, one obtained after immunization with the recom-
binant Gag protein, the other with the recombinant ectodomain
of the transmembrane envelope protein p15E. The speciﬁcity of
the staining was analyzed using uninfected and PERV-A/C
infected 293 cells. When we analyzed the 53 samples from
altogether 38 tissues and organs from pig 385 by immunohisto-
chemistry, a score system was used indicating the intensity of the
staining as well as the percentage of the stained cells (see
Materials and methods). Using this method, cells expressing PERV
proteins were detected in several organs (Figs. 4 and 5, Table 2).
In correlation with the RNA data, a high expression of PERV
proteins was observed in the lungs, the spleen and the lymph
nodes. The highest score (3/3) was found in the spleen (Table 2).
Table 1
Primers and probes used for the PCR and real-time PCR.
Primer/probe Sequence 50–30 Accession number/reference
PCR
PERV gag forward TCCAGGGCTCATAATTTGTC AJ293656
PERV gag reverse TGATGGCCATCCAACATCGA AJ293656
PERV gag probe FAM-AGAAGGGACCTTGGCAGACTTTCT-BHQ1 AJ293656
PERV-A env VRBF for CCTACCAGTTATAATCAATTTAATTATGGC Wood et al. (2004)
PERV-C env TMR rev CTCAAACCACCCTTGAGTAGTTTCC Wood et al. (2004)
PERV pol for TTGACTTGGGAGTGGGACGGGTAAC Czauderna et al. (2000)
PERV pol rev GAGGGTCACCTGAGGGTGTTGGAT Czauderna et al. (2000)
P1 (SDa for) TGCTGTTTGCATCAAGACCGC Karlas et al. (2010)
P2 (SD rev) ACAGACACTCAGAACAGAGAC Karlas et al. (2010)
P3 (SAb rev) ATGGAGGCGAAGCTTAAGGGGA Karlas et al. (2010)
Real-time PCR
PERV pol forward ATGTGGATGAGCGTAAGGGAGTAG AJ293656
PERV pol reverse GTCTGGGGGCTGCCGAACGAT AJ293656
PERV pol probe FAM-TAGGACCATGGAGGAGACCTGTTGCC-BHQ1 AJ293656
pCypc real-time for TGCTTTCACAGAATAATTCCAGGATTTA Duvigneau et al. (2005)
pCyp real-time rev GACTTGCCACCAGTGCCATTA Duvigneau et al. (2005)
pCyp probe Cy5-TGCCAGGGTGGTGACTTCACACGCC-BHQ2 Duvigneau et al. (2005)
envC real-time for CCCCAACCCAAGGACCAG AM229312
envC real-time rev AAGTTTTGCCCCCATTTTAGT AM229312
envC real-time probe FAM-CTCTAACATAACTTCTGGATCAGACCC-BHQ1 AM229312
envC NVd real-time for CCCCAGCCCAAGGACCAG Unpublished
envC NV real-time rev AAGTTTTGTCCCCGTTTTAGT Unpublished
envC NV real-time probe FAM-CTTTAACATAACTTCTGGATCAGACCC-BHQ1 Unpublished
a SD—splice donor.
b SA—splice acceptor.
c pCyp—porcine cyclophilin.
d NV—new variant of PERV-C.
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muscle, colon, and kidney. When one and the same tissue was
stained with both antisera similar patterns were found (Fig. 5).
Expression of PERV proteins was also demonstrated using a
Western blot analysis. Lysates of different organs were prepared
and analyzed using anti-p27Gag and anti-p15E antisera. A low
expression of PERV p27Gag was observed in the spleen, and the
liver, in the other organs no viral proteins were detected using
this method (Fig. 6). No detectable expression of p15E was found
using this method.Discussion
For the ﬁrst time a systematic analysis of PERV expression at
the RNA and protein level was performed using in parallel a
quantitative real-time PCR, immunohistochemistry, and Western
blot analysis in a single Yucatan miniature pig. During the life
time, a high expression of PERV was found in the PBMCs of the
animal. When the expression in different organs was analyzed, in
some organs a high expression, in others a lower expression was
observed. The extent of expression at the RNA level correlated not
always with that at the protein level (Supplementary Table 2).
Expression of mRNA does not automatically mean that proteins
are produced. In addition, the differences between the expression
at the RNA level and the expression at the protein level may be
explained by different sensitivities of the methods. The differ-
ences between the Western blot analyses and the immunohisto-
chemistry investigation may be explained by the presence of
different cell types in the tissues and by conformational epitopes
recognized by the antiserum in the immunohistochemistry, but
not in Western blot analyzes. A good correlation between expres-
sion of protein and full-length mRNA was observed in the lymph
nodes, the lung, and the spleen.
For the ﬁrst time a quantitative real-time PCR was used to study
the expression of PERV at the mRNA level in different organs of a
pig. Although only one animal was analyzed in such a detail,previously smaller studies also described differences in the expres-
sion of PERV in different tissues and organs. For example, PERV
expression was studied in miniature swines using Northern blot
analyzes (Akiyoshi et al., 1998). The highest expression was found
in the lung and the thymus, high expression was found in PBMCs
and mitogen stimulated PBMCs, medium expression was found in
lymph nodes and the spleen and no expression was found in the
kidneys and the heart (Akiyoshi et al., 1998). Using a semiquanti-
tative PCR, Clemenceau et al. (1999) described a high expression of
PERV in the kidneys and the liver of a Large White pig, medium
expression in the thymus, lymph nodes, the spleen, the heart and
the lung, the lowest expression was found in the pancreas. The real-
time PCR used here allowed exact quantiﬁcation of the expression
as well as a control of the quality of the isolated RNA measuring
expression of cellular porcine cyclophilin in a duplex real-time PCR.
The same method has been previously used to study expression in a
very few organs and in the tumor tissues of miniature pigs with
melanomas (Dieckhoff et al., 2007) as well as in transgenic landrace
pigs expressing PERV-speciﬁc shRNA generated to suppress PERV
expression by RNA interference (Dieckhoff et al., 2008; Semaan
et al., 2012). In these studies the highest expression was found in
the spleen and the lung of the animals (Supplementary Table 1).
There is a good correlation between the low expression of PERV
mRNA in organs of landrace pigs (Dieckhoff et al., 2009) compared
with the high expression in the organs of the miniature pig (Fig. 1)
on one hand and between the low expression in PBMCs of landrace
pigs when compared with the high expression in PBMCs of
miniature pigs on the other hand (Dieckhoff et al., 2009), indicating
that the expression in PBMCs is a good marker for the expression in
organs. Therefore analyzes of the expression in unstimulated and
mitogen-stimulated pig PBMCs can be used as an assay to select
animals with a low expression of PERV in the organs.
The expression of PERV proteins in animals was not yet
studied. Using an antiserum against p10Gag no expression was
found in the kidney, aorta and heart of a landrace pig (Krach et al.,
2000). The systematic analysis of protein expression in different
organs of a single animal performed here showed a strong
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Fig. 1. Quantitative analysis of PERV expression in different organs of pig 385 using real-time PCR speciﬁc for PERV. (A) Copy number of PERV mRNA using primers and a
probe corresponding to PERV-pol normalized to ng total RNA, (B) relative expression of PERV using primers and a probe speciﬁc for PERV-gag, (C) percentage of expression of
PERV-C and (D) of a new variant of PERV-C with amino acid exchanges in the receptor binding site of the surface envelope protein, taking the expression in the lung as 100%.
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miniature pig 385 (Figs. 4–6).
The animal 385 investigated here is characterized by an
exceptional high expression of PERV in PBMCs and organs. In
comparison with other strains of pigs, the PERV expression is
generally very high in miniature pigs and mating other pig strains
with miniature pigs increased the expression of PERV in the
PBMCs of the offspring (Dieckhoff et al., 2009). For a rational
selection of animals for xenotransplantation it was recommended
to use pigs with low expression of PERV-A and -B and not to use
pigs containing PERV-C in their genome in order to avoid the
generation of PERV-A/C recombinants (Wood et al., 2004, Denner
et al., 2008,2009). Animal 385 is another example showing that
PERV-A/C recombinants were generated in healthy pigs with high
expression of PERV-A and PERV-C.
It is interesting to compare the expression of PERV in pigs with
that of human endogenous retroviruses (HERVs) in humans. Some
HERV were found expressed in the placenta, but not in other
tissues (de Parseval and Heidmann, 2005). As in the case of PERVs
in pigs, the expression of HERV proteins is also poorly studied and
based on the low mRNA expression no protein expression will be
expected in most organs (for review see Denner, 2010).
Although endogenous retroviruses of mice and cats play a role
in tumor development, it remains unclear whether this is true for
PERVs and HERVs. In contrast to PERVs and murine endogenous
retroviruses which were released as infectious particles, e.g., aftertreatment of PBMCs with mitogens, HERV-K was not expressed in
stimulated human PBMCs (Denner et al., unpublished). The high
expression of PERV in the spleen and lymph nodes (Figs. 1, 4, and 5)
suggests that ongoing immune reactions in these lymphoid
organs may contribute to the elevated expression of PERV and
subsequent recombination between PERV-A and -C.
When the expression of PERV mRNA in Yucatan miniature pig
was compared with that in other pig strains, a low expression was
found in German landrace pigs. This suggests that in the tissues
from these animals no viral proteins will be detected. The same
may be true for Large White, Duroc and Schwa¨bisch-Ha¨llisch
animals (Dieckhoff et al., 2009).Material and methods
Origin and housing of the pig
The Yucatan miniature (micro) pig number 385 was obtained
from Charles River, Saint-Aubin-Les-Elbeuf, France. Born in 1998,
it lived in the animal facility of the Paul Ehrlich Institute since
July 17, 1999, and was euthanized on February 2, 2006. Charles
River determined the SLA haplotype H04/H21. Its weight
increased from 25 to 120 kg.
A B C D E F G H I J + -
815 bp
1500 bp
1200 bp
Fig. 3. Detection of (A) proviruses of PERV-A/C recombinants in the DNA from
some, but not all tissues from pig 385 and (B) detection of pol of PERV as a control
for DNA load. A—heart; B—kidney; C—skin; D—liver; E—lung; F—lymph node;
G—brain; H—spleen; I—small intestine; J—ovary; þ , positive control, 293 cells
infected with PERV-A/C;  , negative control, no template.
F S
LTR gag pol env LTR
SD SA
P1 P2 P3
F S F S F S F S F S F S F S F S
M   C  P   O
spleen No template
control
kidney liver heart lung ovarian brain PK-15
Fig. 2. Detection of full-length and spliced mRNA of PERV in different organs of
animal 385. (A) Design of a PCR assay detecting both types of mRNA, selecting
primers in the LTR (P1, upstream the splice donor SD), P2, downstream the splice
donor SD, and in the env region downstream the splice acceptor SA (P3).
(B) Expression of spliced and unspliced mRNA in different tissues of pig 385
(indicated by arrows). Pig kidney cells PK-15 were used as positive, no template as
negative control. F—full-length mRNA, S—spliced mRNA and (C) Detection of
additional (certainly deleted) variants of spliced env mRNA in PK-15 cells,
M—marker, C—negative control, P—PK-15, O—ovary.
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Pieces of the organs were taken during autopsy and immedi-
ately frozen in liquid nitrogen and later stored at 80 1C.
In parallel, tissue samples were ﬁxed in 4% buffered formalin for
2 day and routinely embedded in parafﬁn. 53 samples from 38
tissues and organs including brain, skin, muscle, liver, lung, blood
vessels, spleen, kidney, uterus and gastrointestinal tract were
taken (Table 2).
Sera and antibodies
Sera from goats 14, 16 and 346, immunized with the recom-
binant ectodomain of the transmembrane envelope protein p15E
of PERV (Kaulitz et al., 2011a), and from goat 30, immunized with
the recombinant p27Gag protein of PERV (Irgang et al., 2003), and
anti-goat antibodies (Dako, 1:700–1:1000) were used. These sera
detected the corresponding recombinant protein used forimmunization as well as the corresponding viral protein in
Western blots (dilution 1:200). A mouse monoclonal antibody
against actin (Sigma, dilution 1:2000) and secondary anti-mouse
antibodies (DAKO, 1:1000) were used.
Immunohistochemistry
Three mm thick sections were stained routinely with hematoxylin
and eosin, and in adjacent serial sections, immunohistochemistry
was performed. The antibodies used were goat monoclonal anti-
bodies to protein p15E of PERV (dilution 1:300) and to the recombi-
nant Gag protein of PERV (dilution 1:300) as described above. The
slides were deparafﬁnized and rehydrated, and then for antigen
retrieval they were pretreated by microwave heating at 98 1C for
15 min in target retrieval solution pH 6 (TRS6, DAKO) two times.
After the antigen retrieval endogenous peroxidase activity was
blocked and then the slides were incubated with the primary
antibody at room temperature for 60 min. The immunohistochemical
reaction was visualized using the ABC-method with AEC (Zymed) as
chromogen. Human 293 cells, either uninfected or infected with
PERV-A/C were pelleted, parafﬁn embedding and used as negative
and positive control, respectively. Staining intensity were assessed as
weak (score 1þ), moderate (score 2þ) and strong (3þ). Expression
of protein p15E and recombinant Gag protein of PERV were deﬁned
as negative (score 0), weakly positive (score 1þ , staining in o10%
cells), moderately positive (score 2þ , staining in 10–50% cells) and
strongly positive (score 3þ , staining in 450% cells).
DNA and RNA isolation from organs
DNA and RNA were isolated using TRI-reagent (Sigma,
Taufkirchen, Germany). The organ samples were homogenized
in the Tissue Lyser LT (Qiagen, Hilden, Germany) together with
TRI-reagent (1 ml per 50 to 100 mg of tissue) and 7 mm stainless
steel beads (Qiagen, Hilden, Germany). After homogenization
0.3 ml chloroform was added and after centrifugation (12,000 g,
15 min, 4 1C) total RNA was puriﬁed from the aqueous phase
using the RNeasy Mini kit (Qiagen, Hilden, Germany), including
an on-column DNase digestion. RNA was stored at 80 1C until
assayed. DNA was isolated from the interphase of the TRI-
reagent/chloroform mixture according to the manufacturer’s
instructions. Isolated DNA was stored at 4 1C until use.
Protein isolation from organs
Protein was isolated by grinding the tissues in liquid nitrogen,
radioimmuno precipitation assay (RIPA) buffer (150 mM NaCl,
5 mM EDTA, 10 mM Tris pH7.2, 0.1% DOC, 0.1% SDS, 1% Triton, 4%
protease inhibitor) was added to the protein powder, it was
transferred to a tube, incubated for one hour at 4 1C, and
centrifuged at 13,000 rpm for 10 min.
Western blot analysis
Proteins of different organs (25 mg) were subjected to denatur-
ing sodium dodecylsulfate-polyacrylamide electrophoresis
(SDS-PAGE) in 12% gels using tricine-buffered systems and
transferred to a polyvinylidene diﬂuoride (PVDF) membrane
(Millipore, Bedford, MA) by semidry electroblotting. The mem-
brane was blocked over night at 4 1C using 0.05% Tween 20 and 5%
skimmed milk in phosphate buffered saline. After blocking, the
membrane was incubated with goat anti-PERV-p27Gag or anti-p15E
serum at a dilution of 1:100 for 2 h at room temperature followed
by incubation at room temperature with a 1:1000 dilution
of a peroxidase-conjugated secondary anti-goat serum (Dako,
Hamburg, Germany) for 1 h. A mouse monoclonal antibody
Fig. 4. Immunohistochemistry of several organs from pig 385 (A—lumbal lymph node, B—cerebrum, C—muscle, D—colon, E—myocard, F—stomach, G—spleen, H—lung,
I—kidney). The kidney and the muscle were stained with serum 16, speciﬁc for PERV p15E, all other tissues were stained with antiserum 30 speciﬁc for PERV Gag. Whereas
A, B, D, E, G and H show expression of recombinant GAG protein of PERV in varying intensities with a granular staining pattern, stomach, kidney and muscle show no
immunoreactivity, original magniﬁcation 400.
Gag p15E
Fig. 5. Comparative immunohistochemistry of the spleen (A, B) and the liver (C, D) from pig 385 using two antisera, A, C—stained with antiserum 30 speciﬁc for PERV Gag,
B, D—stained with antiserum 16, speciﬁc for PERV p15E. Both sera show a similar staining pattern, strong in the case of the spleen and absent in the case of the liver,
original magniﬁcation 400.
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Table 2
Immunhistochemical analysis of different organs of pig 385.
Organ Na Serum 16b (anti-p15E) Serum 30bb (anti-p27Gag) PERV expressing cells
Aorta thorax 1 0 0
Uterus 2 0 0
Brain cerebrum 2 2/2 2/2 Neurons, Microglia, Endothelial cells
Cerebellum 1 1/1 1/1 Neurons, Microglia, Endothelial cells
Thalamus 1 1/1 2/2 Neurons, Microglia, Endothelial cells
Medulla oblangata 1 1/1 2/2 Neurons, Microglia, Endothelial cells
Liver 2 1/1 1/1 Kupffer cells, Hepatocytes, Endothelial cells
Lung 3 1/2 2/2 Macrophages, Endothelial cells, Alveolar epithelial cells
Thymus 1 0 0
Parathyroidea 1 0 0
Lymph node cervical 1 0 0
Lymph node mesenterial 1 2/2 2/2 Sinus endothelial cells, Histiocytes
Lymph node lumbal medial 1 2/2 2/2 Sinus endothelial cells, Histiocytes
Lymph node inguinal superﬁcial 1 2/2 2/2 Sinus endothelial cells, Histiocytes
Spleen 2 3/3 3/3 Sinus endothelial cells, Histiocytes
Kidney 2 0 0
Ovar 2 0 0
Pancreas 3 0 0
Vagina 1 0 0
Anterior vena cava 1 0 0
Anterior vena cava 1 0 0
Vena lienalis 1 0 0
Renal vein 1 0 0
Vena femoralis 1 0 0
Heart 5 2/2 2/2 Cardiomyocytes
Small intestine 1 0 0
Colon 2 2/1 2/1 Lymphocytes
Gastric corpus 1 0 0
Gastric antrum 1 0 0
Masseter 1 0 0
Back muscle 1 2/1 2/1 Myocytes
Upper arm muscle 1 0 0
Rear inner thigh muscle 1 2/1 2/1 Myocytes
Thigh muscle 1 2/1 2/1 Myocytes
Cheek skin 1 1/1 1/1 Epidermis
Skin back 1 1/1 1/1 Epidermis
Abdominal skin 1 0 0
Buttock skin 1 0 0
a Number of samples studied.
b Staining intensity (score 0–3)/percentage of stained cells (score 0–3).
Actin
43 kDa
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Gag
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Fig. 6. Western blot analyzes of different organs of pig 385 and controls; Upper picture: A—lysate of 293 cells infected with PERV-A/C (13 mg); B—recombinant PERV Gag
(70ng); lysates of C—spleen; D—kidney; E—lung; F—liver; G—lymph node (25 mg each). An antiserum speciﬁc for PERV Gag was used and the protein loading was
analyzed using an antiserum against actin. Lower picture: A—lysate of 293 cells infected with PERV-A/C (13 mg); B—recombinant PERV Gag (70 ng); C—recombinant p15E
(70 ng), lysates of D—spleen; E—lung; F—kidney, G—liver; H—lymph node, I—uterus (25 mg each). An antiserum speciﬁc for p15E of PERV was used.
I. Bittmann et al. / Virology 433 (2012) 329–336 335against actin was used as control. Antibody binding was visua-
lized using an enhanced chemiluminescence-based system (GE
Healthcare, Buckinghamshire, UK).
PCR and real-time RT-PCR
A quantitative real time one-step RT-PCR was performed using
the Invitrogen SuperScript III platinum system, the MX3000thermocycler (Stratagene), probe and primers speciﬁc for PERV
gag, pol, envC and the new variant of envC (Sigma) (Table 1). PERV
expression was normalized to the amount of total RNA as well as
to the expression of the reference gene porcine cyclophilin (pCyp)
(Table 1). The 25 ml reaction mixture consisted of 12.5 ml reaction
mix (0.4 mM of each dNTP, 6 mM MgSO4), 0,5 ml (10 mM) of each
primer, 0.5 ml (10 mM) of both probes, 0.5 ml Super Script/Platinum
Taq Mix, 4 ml nuclease free water and 5 ml total RNA (10 ng/ml).
I. Bittmann et al. / Virology 433 (2012) 329–336336The following temperature conditions were used: 50 1C, 15 min;
95 1C, 2 min; 45 cycles (95 1C, 15 s; 54 1C, 30 s). Data were
analyzed using the DDCT-method (Livak and Schmittgen, 2001).
The absence of DNA contaminations was controlled performing
the assays in parallel without the RT. In order to detect full-length
and spliced mRNA speciﬁc primers were used (Table 1, Fig. 2).
To analyze the presence of recombinant PERV-A/C, a PCR was
performed using the primers PERV-A env VRBF for and PERV-C
env TMR rev (Table 1) at the conditions 94 1C, 15 min; 40 cycles
(94 1C, 30 s; 55 1C, 30 s; 72 1C, 2 min) and 72 1C, 10 min were used
to secreen for PERV-A/C sequences.
Infection experiments
Cell-free supernatants from PBMCs incubated with medium or
PHA were incubated with human 293 cells using 8 mg/ml poly-
brene. PERV infection was measured as provirus integration using
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